Announcement on Using Idle Self-owned Funds for Cash Management
Filed with SSE · · 3 pages · Chinese
Zhejiang Ausun Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Ausun Pharmaceutical
- Announcement on Obtaining European CEP Certificate for Active Pharmaceutical Ingredient of Pilocarpine Hydrochloride
- Announcement on Initially Repurchasing Shares through Call Auction and Progress in Shares Repurchase
- Announcement on Obtaining Loan Commitment Letter for Share Repurchase from Financial Institutions
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Not Subject to Sales Restrictions Concerning Share Repurchase
- Announcement on the Plan for Repurchasing Shares through Call Auction
Later from Zhejiang Ausun Pharmaceutical
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 8th Meeting of the 4th Board of Directors
- Announcement on Obtaining of the "Drug Registration Certificate" for the Cooperative Product Imatinib Mesylate Tablets
Follow Zhejiang Ausun Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Ausun Pharmaceutical